OSE Immunotherapeutics SA

09/18/2019 | Press release | Distributed by Public on 09/18/2019 10:23

OSE Immunotherapeutics Receives a Milestone Payment of €5.4 Million From Bpifrance for SIRPα-Antagonist Monoclonal Antibody BI 765063